• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海绵体内血管活性药物在克服脊髓损伤所致阳痿方面的作用。

The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.

作者信息

Earle C M, Keogh E J, Ker J K, Cherry D J, Tulloch A G, Lord D J

机构信息

Reproductive Medicine Research Institute, Sir Charles Gairdner Hospital, Nedlands, Western Australia.

出版信息

Paraplegia. 1992 Apr;30(4):273-6. doi: 10.1038/sc.1992.68.

DOI:10.1038/sc.1992.68
PMID:1625897
Abstract

Twenty-two spinal cord injured men (mean age 35.2 years) referred because of impotence were treated with intracavernosal vasoactive agents. Papaverine 2-20 mg, papaverine 40 mg plus phentolamine 0.5 mg or prostaglandin E1 (1-20 micrograms) were used. Nineteen responded and were taught to self administer the medication with varying degrees of assistance from their partners. Fourteen men participated in a postal survey; 12 (86%) continued to use the drugs every 1 to 4 weeks and reported satisfaction with the method. Partner responses were positive in half of the group and when not so it influenced the patients to abandon or reduce the frequency of treatment. Counselling was essential to allay anxiety. Clinical management was not compromised and side effects were minimal. Overall we found this treatment effective, safe and worthwhile.

摘要

22名因阳痿前来就诊的脊髓损伤男性(平均年龄35.2岁)接受了海绵体内血管活性药物治疗。使用了2 - 20毫克罂粟碱、40毫克罂粟碱加0.5毫克酚妥拉明或前列腺素E1(1 - 20微克)。19人有反应,并在伴侣不同程度的协助下学会了自行给药。14名男性参与了邮寄调查;12人(86%)每1至4周继续使用这些药物,并报告对该方法满意。一半的伴侣反应积极,若不然则会影响患者放弃或减少治疗频率。咨询对于缓解焦虑至关重要。临床管理未受影响,副作用极小。总体而言,我们发现这种治疗有效、安全且值得。

相似文献

1
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.海绵体内血管活性药物在克服脊髓损伤所致阳痿方面的作用。
Paraplegia. 1992 Apr;30(4):273-6. doi: 10.1038/sc.1992.68.
2
Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.勃起功能障碍男性阴茎海绵体内注射前列腺素E1后获得满意硬度的决定因素。
Int J Impot Res. 1996 Mar;8(1):9-16.
3
Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.脊髓损伤所致勃起功能障碍患者海绵体内注射前列腺素E1:初步报告
Paraplegia. 1995 Dec;33(12):731-3. doi: 10.1038/sc.1995.153.
4
Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.海绵体内注射血管活性药物,是治疗脊髓损伤患者阳痿的一种替代方法。
Paraplegia. 1986 Oct;24(5):271-5. doi: 10.1038/sc.1986.37.
5
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.前列腺素E1联合酚妥拉明治疗勃起功能障碍
Int J Impot Res. 1996 Mar;8(1):5-7.
6
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].[阴茎海绵体内药物治疗用于阳痿的治疗与评估]
Harefuah. 1991 Oct;121(7-8):223-5.
7
[Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].[阴茎注射血管活性药物联合治疗452例勃起功能障碍患者的评估]
Harefuah. 1998 May 1;134(9):673-8, 750.
8
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.对患有勃起功能障碍的糖尿病男性进行海绵体内注射的长期治疗。
Asian J Androl. 2006 Mar;8(2):219-24. doi: 10.1111/j.1745-7262.2006.00095.x.
9
[Intracavernous injection of vasoactive drugs for treating erectile impotence].[海绵体内注射血管活性药物治疗勃起功能障碍]
Hinyokika Kiyo. 1988 Feb;34(2):301-4.
10
Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic.前列腺素E1在泌尿生殖医学门诊勃起功能障碍治疗中的应用
Ulster Med J. 1994 Apr;63(1):18-22.

引用本文的文献

1
The treatment of erectile dysfunction in patients with neurogenic disease.神经源性疾病患者勃起功能障碍的治疗
Transl Androl Urol. 2016 Feb;5(1):88-101. doi: 10.3978/j.issn.2223-4683.2016.01.07.
2
Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application.脊髓损伤对性功能的影响:广泛的临床实践干预与实际应用
J Spinal Cord Med. 2012 Jul;35(4):211-8. doi: 10.1179/2045772312Y.0000000025.
3
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.
海绵体内注射前列地尔。其药效学、药代动力学特性及在勃起功能障碍中的治疗潜力综述。
Drugs Aging. 1996 Jan;8(1):56-74. doi: 10.2165/00002512-199608010-00009.
4
Intracavernous prostaglandin E1 in erectile dysfunction.阴茎海绵体内注射前列腺素E1治疗勃起功能障碍
Clin Investig. 1994 Jan;72(2):139-49. doi: 10.1007/BF00184593.